233 related articles for article (PubMed ID: 27258482)
21. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
[TBL] [Abstract][Full Text] [Related]
22. Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers.
Zhao X; Zhao J; Lin ZY; Pan G; Zhu Y; Cheng Y; Cui W
Colloids Surf B Biointerfaces; 2015 Jun; 130():1-9. PubMed ID: 25879640
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
25. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
26. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma.
Zavareh S; Mahdi M; Erfanian S; Hashemi-Moghaddam H
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1073-1084. PubMed ID: 27752764
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging.
Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L
Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726
[TBL] [Abstract][Full Text] [Related]
31. Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells.
Medina SH; Chevliakov MV; Tiruchinapally G; Durmaz YY; Kuruvilla SP; Elsayed ME
Biomaterials; 2013 Jun; 34(19):4655-66. PubMed ID: 23523429
[TBL] [Abstract][Full Text] [Related]
32. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
33. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
34. Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma.
Wang Z; Shao D; Chang Z; Lu M; Wang Y; Yue J; Yang D; Li M; Xu Q; Dong WF
ACS Nano; 2017 Dec; 11(12):12732-12741. PubMed ID: 29140684
[TBL] [Abstract][Full Text] [Related]
35. Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy.
Liu Y; Dai R; Wei Q; Li W; Zhu G; Chi H; Guo Z; Wang L; Cui C; Xu J; Ma K
ACS Appl Mater Interfaces; 2019 Nov; 11(47):44582-44592. PubMed ID: 31682097
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
38. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging.
Yang Y; Aw J; Chen K; Liu F; Padmanabhan P; Hou Y; Cheng Z; Xing B
Chem Asian J; 2011 Jun; 6(6):1381-9. PubMed ID: 21548100
[TBL] [Abstract][Full Text] [Related]
39. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
